ACO Overhaul Issued Amid Looming Regulations
Dec. 21—An overhaul of Medicare’s accountable care organization (ACO) program, issued today, is among several far-reaching federal regulations that hospital leaders and advocates have been anxiously awaiting, all of which could be released within the next week.
CY 2019 MPFS Final Rule Executive Summary Presentation
This presentation briefly summarizes the CY 2019 updates to payments and other programs contained in the MPFS final rule, published by CMS.
Hospitals Issue Warnings on ACA Repeal Ruling
Dec. 17—Hospital advocates raised a range of concerns about the expected impacts of striking down the Affordable Care Act (ACA) after a federal judge’s recent decision that the law was invalid.
Dec. 17-21: Report Highlights Savings of Existing Medicare ACOs
Dec. 13—As the Trump administration considers a controversial overhaul of Medicare’s accountable care organization (ACO) program, a new report says the existing model has provided much more savings than previously found.
CY 2019 OPPS/ASC Final Rule: HFMA Executive Summary Presentation
This presentation briefly summarizes the CY 2019 OPPS/ASC final rule, published by CMS.
Medicare Enrollment Rate Will Peak in 2030
Medicare enrollment rate will increase by approximately 44 percent by 2030. After that time, the numbers will increase at much slower rates.
Hospitals Sue over $380 Million OPPS Cut
Dec. 5—Several hospitals and advocacy groups filed suit this week to stop a finalized Medicare payment change that would cut 2019 outpatient payments by an estimated $380 million.
The Blurring Boundaries of Elder Care: Implications for Providers and Patients
Healthcare providers are planning to invest in home health, palliative and end-of-life care, and geriatric caretakers in the coming years.
CY 2019 Medicare Physician Fee Schedule Final Rule
This document briefly summarizes the payment rate updates under the CY 2019 Medicare Physician Fee Schedule final rule, published by CMS.
Long-Delayed 340B Rule Takes Effect in January
Nov. 30—A highly anticipated rule to require better drug company compliance with a major discount drug program will go into effect Jan. 1—following multiple delays.